Saudi Arabia Continuous Glucose Monitoring Market Size - By Component, By End Use - Forecast, 2025 - 2034

Saudi Arabia Continuous Glucose Monitoring Market Size

The Saudi Arabia continuous glucose monitoring market size was valued at USD 92.2 million in 2024. The market is expected to grow from USD 104.2 million in 2025 to USD 344.2 million in 2034, growing at a CAGR of 16.1% from 2025 to 2034, according to the latest report published by Global Market Insights Inc.

This steady growth is stimulated by various factors such as rising prevalence of diabetes across Saudi Arabia, technological advancements in continuous glucose monitoring devices, increasing awareness pertaining to diabetes through government initiatives and public health campaigns, and rising obesity rates and lifestyle-related health issues. Continuous glucose monitoring (CGM) is an advanced diagnostic device used to track blood glucose levels continuously throughout the day and night. These systems use a small sensor inserted under the skin to measure interstitial glucose levels. Major companies in the industry include Abbott Laboratories, Dexcom, Med Trust, Medtronic, and Sinocare.
 

The market increased from USD 65.1 million in 2021 to USD 81.6 million in 2023. The high diabetes prevalence in Saudi Arabia is a major factor accelerating the market growth. For instance, according to the International Diabetes Federation (IDF), in 2024, Saudi Arabia had a total adult population of approximately 25 million, with a diabetes prevalence rate of 23.1%, amounting to over 5.3 million adults living with diabetes. Moreover, Saudi Arabia is one of the 21 countries and territories in the IDF Middle East and North Africa (MENA) region, which currently has 85 million people affected. This number is expected to rise significantly by 2050, reaching 163 million across the region. This rising trend has created a growing demand for better diagnostic technologies, earlier detection methods, and more effective monitoring options. Thus, as the number of affected individuals increases, healthcare providers and industry leaders are stepping up their efforts and investments to address this urgent medical challenge, propelling the adoption of technologically advanced continuous glucose monitoring across the country for efficient blood glucose monitoring, which in turn is accelerating the market growth in the country.
 

Additionally, increasing obesity rates and lifestyle-related health issues are key contributors to the development of diabetes, which in turn shapes continuous glucose monitoring adoption rates across Saudi Arabia. For instance, according to the data published in the Saudi Pharmaceutical Journal, the prevalence of obesity in Saudi Arabia ranged from 20% to 39% and up to 19.4% among adults and adolescents, respectively. These shifts have led to an increase in the adoption of glucose monitoring devices in managing chronic diabetes conditions resulting from lifestyle-related health issues.
 

Continuous Glucose Monitoring (CGM) is a wearable medical technology used primarily by people with diabetes to track glucose levels in real time. A small sensor placed just under the skin measures glucose in the interstitial fluid (the fluid between cells), and a transmitter sends this data to a receiver, smartphone, or insulin pump.
 

Saudi Arabia Continuous Glucose Monitoring Market Trends

• Technological advancements in continuous glucose monitoring (CGM), which is estimated to reach USD 47.1 billion by 2034, are fundamentally influencing market growth in Saudi Arabia. Advances in sensor accuracy, smaller devices, increased comfort, and improved connectivity with mobile devices and insulin pump devices have helped patients engage more effectively.
   
• Moreover, the combination of CGM, mobile phones, and insulin pump has enabled them to exchange data and dispense insulin automatically, facilitating the development of new technologies. One of them is Medtronic's MiniMed 780G artificial pancreas technology. This device can be paired with a CGM and incorporates complex predictive algorithms to autonomously adjust insulin delivery in real-time, enhancing blood glucose control and potentially minimizing hypoglycemia.
   
• Additionally, modern CGMs are now leveraging AI analytics to provide predictions regarding glucose changes and personalized approaches to treatment decisions. These smart technologies are advancing accuracy, along with providing patients and healthcare providers with the information needed for individualized care plans.
   
• Thus, as CGM technology continues to change the landscape of diabetes management, it is expected to integrate even more into larger health monitoring systems supporting personalized diabetes care. Therefore, such technological advancement is stimulating the market growth in the country.
   

Saudi Arabia Continuous Glucose Monitoring Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on component, the market is segmented into transmitters, sensors, and receivers. The sensor segment was valued at USD 46.3 million in 2024 and is projected to reach USD 175.6 million by 2034, growing at a CAGR of 16.3%. In comparison, the transmitter segment was valued at USD 41.8 million in 2024 and is expected to grow to USD 154.3 million by 2034, with a CAGR of 15.9%.
 

• Sensors in CGM systems are small, wearable devices that are inserted just below the skin surface and measure glucose concentrations in the interstitial fluid. Sensors are a crucial element that allows for real-time glucose monitoring, with a wear time of 7–14 days before needing to be replaced.
   
• Sensors provide continuous and automatic glucose readings without the need for repetitive finger-prick tests and provide real-time glucose data that allow end users and healthcare professionals to make timely decisions and modifications to diabetes management and lifestyle.
   
• For instance, Dexcom’s G7 sensor is a compact, all-in-one wearable device that delivers continuous, real-time glucose readings. It is known for its high accuracy, fast warm-up time, and seamless integration with smartphones and smartwatches, offering users a highly convenient and discreet monitoring experience.
   
• Moreover, features such as extended wear time, improvements in interstitial fluid biocompatibility, coordinating systems with mobile applications, and various other factors have increased awareness and adoption of these sensors.
   
• Additionally, with increasing improvements in artificial intelligence and predictive analytics technology, the future lies in sensors as they will be the core of CGM systems, accelerating the segment growth in the foreseeable future.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the Saudi Arabia continuous glucose monitoring market is bifurcated into hospitals, home care settings, diagnostic centers and clinics, and other end users. The home care settings segment held a significant revenue of USD 74.4 million in 2024 with a revenue share of 80.8%.
 

• CGM devices offer continuous, real-time glucose data monitoring without healthcare worker intervention. This enables home care diabetes patients to manage their condition more effectively, improving therapy adherence and health outcomes.
   
• Moreover, the increased prevalence of diabetes, combined with the demand for customization of care and remote monitoring, has pushed the acceptance of CGM in home settings. The advancement of user-friendly design and mobile application integration has made the devices more accessible to home care users.
   
• For instance, Abbott’s FreeStyle Libre system is designed for easy, at-home glucose monitoring. Its wearable sensor allows users to scan and view glucose levels on their smartphone without a fingerstick. This convenience has made it highly popular among patients managing diabetes independently, contributing significantly to the growth of the home care CGM segment.
   
• Therefore, as technology advances, CGMs are increasingly tailored for personal use, making home care the fastest-growing segment in the Saudi Arabia CGM market.
   

Saudi Arabia Continuous Glucose Monitoring Market Share

• The leading players in the Saudi Arabia CGM market, Abbott Laboratories, Dexcom, Med Trust, Medtronic, and Sinocare, collectively hold around 98% of the market share. These companies are strengthening their presence through continuous innovation, alignment with local regulatory standards, and strategic collaborations. Their focus is on developing advanced CGM systems with longer wear duration, improved accuracy, and seamless digital integration, supporting both clinical and home-based diabetes care across the country.
   
• Manufacturers are actively introducing real-time CGM systems that offer continuous glucose tracking, predictive alerts, and cloud-based data sharing. These features are designed to reduce diabetes-related complications and improve glycemic control by enabling proactive, data-driven decisions and remote patient monitoring across various demographics.
   

 Saudi Arabia Continuous Glucose Monitoring Market Companies

Some of the eminent participants operating in the Saudi Arabia continuous glucose monitoring industry include:

• Abbott Laboratories
• A. Menarini Diagnostics
• Dexcom
• Med Trust
• Medtronic
• Sinocare

• Abbott Laboratories

Abbott Laboratories offers a comprehensive portfolio of CGM products that have fuelled broad adoption and notable market growth. Its FreeStyle Libre systems are widely praised for their innovative features and ease of access, making them popular choices among users worldwide.
 

• Dexcom

Dexcom maintains a strong commitment to research and development, consistently pushing the boundaries of CGM technology. Its dedication to innovation has resulted in state-of-the-art products that improve both user experience and clinical outcomes.
 

• Medtronic

Medtronic utilizes its expansive global footprint spanning over 150 countries to enhance its market presence through a strong distribution network. Its CGM product lineup includes both standalone systems and integrated solutions, such as CGM devices combined with automated insulin pumps, offering a comprehensive approach to diabetes management.
 

Saudi Arabia Continuous Glucose Monitoring Industry News:

• In August 2024, Abbott Laboratories entered into a significant global partnership with Medtronic to integrate its Continuous Glucose Monitoring (CGM) technology with Medtronic's insulin delivery systems. This collaboration aims to enhance diabetes care for patients using both Type 1 and Type 2 diabetes treatments. This partnership is anticipated to enhance access to CGM devices worldwide.
   

The Saudi Arabia continuous glucose monitoring market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Transmitters
• Sensors
• Receivers

Market, By End Use

• Hospitals
• Home care setting
• Diagnostic centres and clinics
• Other end use